Sunshine Act Fallout: Firms Worry About Whistleblower Suits, Reporting Details
Authors are furious about publication expenditures firms have reported to CMS; companies continue to debate whether to report study drugs and are finding numerous errors on Open Payments website.
You may also be interested in...
CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.
Governor Cuomo will establish two panels, one examining safety and efficacy and another considering distribution and pricing, to advise the state on how to approach use of coronavirus vaccines once one is approved.
New proposed rule says a manufacturer’s knowledge of the unapproved use of a product does not alone determine intended use. Former FDA lawyer says rule could set off fireworks over the scope of what the agency considers evidence of off-label use.